OpenAlex
PricingAboutJobs
Log inGet started
Work

The MDM2 Inhibitor AMG 232 Demonstrates Robust Antitumor Efficacy and Potentiates the Activity of p53-Inducing Cytotoxic Agents

HTML

Year: 2015
Type: article
Source: Molecular Cancer Therapeutics
DOI: 10.1158/1535-7163.mct-14-0710
Authors: Jude Canon, Tao Osgood, Steven H. Olson, Anne Y. Saiki, Rebecca Robertson, Dongyin Yu, John Eksterowicz, Qiuping Ye, Lixia Jin, Ada Chen, Jing Zhou, David Cordover, Stephen Kaufman, Richard Kendall, Jonathan D. Oliner, Angela Coxon, Robert Radinsky
Institution: Amgen (United States)
Language: English

Topic: Cancer-related Molecular Pathways
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: MDM2 inhibitors, p53 activation, p53-MDM2 interaction, combination chemotherapy, DNA damage, cell cycle arrest, apoptosis, tumor xenografts, MDM2 amplification, antitumor efficacy
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2094916879
FWCI: 4.467
Cites: 18
Cited by: 157
Related to: 9
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security